Literature DB >> 18272843

Reciprocal regulation of plasma apelin and vasopressin by osmotic stimuli.

Michel Azizi1, Xavier Iturrioz, Anne Blanchard, Séverine Peyrard, Nadia De Mota, Nicolas Chartrel, Hubert Vaudry, Pierre Corvol, Catherine Llorens-Cortes.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18272843      PMCID： PMC2386722          DOI： 10.1681/ASN.2007070816

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN： 1046-6673            Impact factor:   10.121


× No keyword cloud information.
  44 in total

1.  The novel peptide apelin lowers blood pressure via a nitric oxide-dependent mechanism.

Authors:  K Tatemoto; K Takayama; M X Zou; I Kumaki; W Zhang; K Kumano; M Fujimiya
Journal:  Regul Pept       Date:  2001-06-15

2.  Molecular properties of apelin: tissue distribution and receptor binding.

Authors:  Y Kawamata; Y Habata; S Fukusumi; M Hosoya; R Fujii; S Hinuma; N Nishizawa; C Kitada; H Onda; O Nishimura; M Fujino
Journal:  Biochim Biophys Acta       Date:  2001-04-23

3.  Physiological role of a novel neuropeptide, apelin, and its receptor in the rat brain.

Authors:  A Reaux; N De Mota; I Skultetyova; Z Lenkei; S El Messari; K Gallatz; P Corvol; M Palkovits; C Llorens-Cortès
Journal:  J Neurochem       Date:  2001-05       Impact factor: 5.372

Review 4.  Dendritic release of vasopressin and oxytocin.

Authors:  M Ludwig
Journal:  J Neuroendocrinol       Date:  1998-12       Impact factor: 3.627

5.  Characterization of apelin, the ligand for the APJ receptor.

Authors:  D K Lee; R Cheng; T Nguyen; T Fan; A P Kariyawasam; Y Liu; D H Osmond; S R George; B F O'Dowd
Journal:  J Neurochem       Date:  2000-01       Impact factor: 5.372

6.  Cloning, pharmacological characterization and brain distribution of the rat apelin receptor.

Authors:  N De Mota ; Z Lenkei; C Llorens-Cortès
Journal:  Neuroendocrinology       Date:  2000-12       Impact factor: 4.914

7.  Distribution of mRNA encoding B78/apj, the rat homologue of the human APJ receptor, and its endogenous ligand apelin in brain and peripheral tissues.

Authors:  A M O'Carroll; T L Selby; M Palkovits; S J Lolait
Journal:  Biochim Biophys Acta       Date:  2000-06-21

Review 8.  Osmoreceptors in the central nervous system.

Authors:  C W Bourque; S H Oliet
Journal:  Annu Rev Physiol       Date:  1997       Impact factor: 19.318

9.  Isolation and characterization of a novel endogenous peptide ligand for the human APJ receptor.

Authors:  K Tatemoto; M Hosoya; Y Habata; R Fujii; T Kakegawa; M X Zou; Y Kawamata; S Fukusumi; S Hinuma; C Kitada; T Kurokawa; H Onda; M Fujino
Journal:  Biochem Biophys Res Commun       Date:  1998-10-20       Impact factor: 3.575

10.  Distribution of apelin-synthesizing neurons in the adult rat brain.

Authors:  A Reaux; K Gallatz; M Palkovits; C Llorens-Cortes
Journal:  Neuroscience       Date:  2002       Impact factor: 3.590
View more
  37 in total

Review 1.  The apelinergic system: a perspective on challenges and opportunities in cardiovascular and metabolic disorders.

Authors:  Eric Marsault; Catherine Llorens-Cortes; Xavier Iturrioz; Hyung J Chun; Olivier Lesur; Gavin Y Oudit; Mannix Auger-Messier
Journal:  Ann N Y Acad Sci       Date:  2019-06-25       Impact factor: 5.691

2.  By interacting with the C-terminal Phe of apelin, Phe255 and Trp259 in helix VI of the apelin receptor are critical for internalization.

Authors:  Xavier Iturrioz; Romain Gerbier; Vincent Leroux; Rodrigo Alvear-Perez; Bernard Maigret; Catherine Llorens-Cortes
Journal:  J Biol Chem       Date:  2010-07-30       Impact factor: 5.157

3.  Vasopressin and hydration play a major role in the development of glucose intolerance and hepatic steatosis in obese rats.

Authors:  Christopher Taveau; Catherine Chollet; Ludovic Waeckel; Dorinne Desposito; Daniel G Bichet; Marie-Françoise Arthus; Christophe Magnan; Erwann Philippe; Valerie Paradis; Fabienne Foufelle; Isabelle Hainault; Sofia Enhorning; Gilberto Velho; Ronan Roussel; Lise Bankir; Olle Melander; Nadine Bouby
Journal:  Diabetologia       Date:  2015-01-27       Impact factor: 10.122

4.  Role of fructose and fructokinase in acute dehydration-induced vasopressin gene expression and secretion in mice.

Authors:  Zhilin Song 宋志林; Carlos A Roncal-Jimenez; Miguel A Lanaspa-Garcia; Sarah A Oppelt; Masanari Kuwabara; Thomas Jensen; Tamara Milagres; Ana Andres-Hernando; Takuji Ishimoto; Gabriela E Garcia; Ginger Johnson; Paul S MacLean; Laura-Gabriela Sanchez-Lozada; Dean R Tolan; Richard J Johnson
Journal:  J Neurophysiol       Date:  2016-11-16       Impact factor: 2.714

5.  Antinatriuretic effect of vasopressin in humans is amiloride sensitive, thus ENaC dependent.

Authors:  Anne Blanchard; Michael Frank; Grégoire Wuerzner; Severine Peyrard; Lise Bankir; Xavier Jeunemaitre; Michel Azizi
Journal:  Clin J Am Soc Nephrol       Date:  2011-01-13       Impact factor: 8.237

Review 6.  Regulation of the Apelinergic System and Its Potential in Cardiovascular Disease: Peptides and Small Molecules as Tools for Discovery.

Authors:  Sanju Narayanan; Danni L Harris; Rangan Maitra; Scott P Runyon
Journal:  J Med Chem       Date:  2015-07-10       Impact factor: 7.446

7.  Apelin acts in the subfornical organ to influence neuronal excitability and cardiovascular function.

Authors:  Li Dai; Pauline M Smith; Markus Kuksis; Alastair V Ferguson
Journal:  J Physiol       Date:  2013-04-29       Impact factor: 5.182

Review 8.  The apelin receptor: physiology, pathology, cell signalling, and ligand modulation of a peptide-activated class A GPCR.

Authors:  Nigel A Chapman; Denis J Dupré; Jan K Rainey
Journal:  Biochem Cell Biol       Date:  2014-08-20       Impact factor: 3.626

Review 9.  Apelin/APJ system: a promising therapy target for hypertension.

Authors:  Di Wu; Lu He; Linxi Chen
Journal:  Mol Biol Rep       Date:  2014-07-03       Impact factor: 2.316

10.  Abnormal fluid homeostasis in apelin receptor knockout mice.

Authors:  Emma M Roberts; Michael J F Newson; George R Pope; Rainer Landgraf; Stephen J Lolait; Anne-Marie O'Carroll
Journal:  J Endocrinol       Date:  2009-07-03       Impact factor: 4.286
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.